NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 51 min ago

Notice to Extend the Expiration Date for the Mentored Patient-Oriented Research Career Development Awards (Parent K23s)

Thu, 2024-05-02 02:11
Notice NOT-OD-24-113 from the NIH Guide for Grants and Contracts

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)

Thu, 2024-05-02 02:10
Funding Opportunity PAR-24-202 from the NIH Guide for Grants and Contracts. This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

Notice of Fiscal Policies in Effect for FY 2024

Tue, 2024-04-30 13:47
Notice NOT-OD-24-109 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research

Tue, 2024-04-30 11:11
Notice NOT-OD-24-096 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Exploring the Effects of Endocannabinoids and Exogenous Cannabinoids on Brain Development

Tue, 2024-04-30 02:06
Notice NOT-DA-25-030 from the NIH Guide for Grants and Contracts

Notice of Legislative Mandates in Effect for FY 2024

Tue, 2024-04-30 02:05
Notice NOT-OD-24-110 from the NIH Guide for Grants and Contracts

Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)

Mon, 2024-04-29 12:42
Funding Opportunity RFA-MH-25-185 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)

Mon, 2024-04-29 12:42
Funding Opportunity RFA-MH-25-186 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)

Mon, 2024-04-29 10:35
Funding Opportunity RFA-DK-25-005 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the Type 1 Diabetes TrialNet Clinical Network Hub (HUB), a screening and clinical activities coordination unit for clinical trials focusing on the prevention of and early intervention in type 1 diabetes (T1D). The main objective of the HUB is to increase the efficiency and productivity of the TrialNet network by providing coordination of communications and outreach and developing new tools and approaches to increase screening, recruitment and retention. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Pages